These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9245615)

  • 21. Generation of HIV latency during thymopoiesis.
    Brooks DG; Kitchen SG; Kitchen CM; Scripture-Adams DD; Zack JA
    Nat Med; 2001 Apr; 7(4):459-64. PubMed ID: 11283673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the signal transducer and activator of transcription 1 signaling pathway in thymocytes from HIV-1-infected human thymus.
    Miller ED; Smith JA; Lichtinger M; Wang L; Su L
    AIDS; 2003 Jun; 17(9):1269-77. PubMed ID: 12799548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a human thymic organ culture model for the study of HIV pathogenesis.
    Bonyhadi ML; Su L; Auten J; McCune JM; Kaneshima H
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1073-80. PubMed ID: 8554904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans.
    Bonyhadi ML; Kaneshima H
    Mol Med Today; 1997 Jun; 3(6):246-53. PubMed ID: 9211415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porcine thymic grafts protect human thymocytes from HIV-1-induced destruction.
    Hongo D; Hadidi S; Damrauer S; Garrigue V; Kraft D; Sachs DH; Nikolic B; Sykes M
    J Infect Dis; 2007 Sep; 196(6):900-10. PubMed ID: 17703422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
    Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV type 1 infection alters cytokine mRNA expression in thymus.
    Koka PS; Brooks DG; Razai A; Kitchen CM; Zack JA
    AIDS Res Hum Retroviruses; 2003 Jan; 19(1):1-12. PubMed ID: 12581511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Model of viral infection in SCID mice: SCID-hu mouse and hu-PBL-SCID mouse].
    Koyanagi Y
    Uirusu; 1999 Jun; 49(1):33-9. PubMed ID: 10548937
    [No Abstract]   [Full Text] [Related]  

  • 30. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
    Kollmann TR; Pettoello-Mantovani M; Katopodis NF; Hachamovitch M; Rubinstein A; Kim A; Goldstein H
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3126-31. PubMed ID: 8610180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of the SCID-hu mouse by HIV-1.
    Namikawa R; Kaneshima H; Lieberman M; Weissman IL; McCune JM
    Science; 1988 Dec; 242(4886):1684-6. PubMed ID: 3201256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of IL-7 on early human thymocyte progenitor cells in vitro and in SCID-hu Thy/Liv mice.
    Napolitano LA; Stoddart CA; Hanley MB; Wieder E; McCune JM
    J Immunol; 2003 Jul; 171(2):645-54. PubMed ID: 12847229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
    Goldstein H; Pettoello-Mantovani M; Anderson CM; Cordelier P; Pomerantz RJ; Strayer DS
    J Infect Dis; 2002 May; 185(10):1425-30. PubMed ID: 11992277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and applications of the SCID-hu mouse model.
    McCune JM
    Semin Immunol; 1996 Aug; 8(4):187-96. PubMed ID: 8883141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of HIV infection in AZT-treated SCID-hu mice.
    McCune JM; Namikawa R; Shih CC; Rabin L; Kaneshima H
    Science; 1990 Feb; 247(4942):564-6. PubMed ID: 2300816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cytokines on HIV-induced depletion of thymocytes in vivo.
    Uittenbogaart CH; Boscardin WJ; Anisman-Posner DJ; Koka PS; Bristol G; Zack JA
    AIDS; 2000 Jul; 14(10):1317-25. PubMed ID: 10930145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV induces thymus depletion in vivo.
    Bonyhadi ML; Rabin L; Salimi S; Brown DA; Kosek J; McCune JM; Kaneshima H
    Nature; 1993 Jun; 363(6431):728-32. PubMed ID: 8100043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.